128 related articles for article (PubMed ID: 2096993)
41. Establishment of pharmacological doses of estrogen-dependent mammary tumors with estrogen and progesterone receptors.
Yoshida H; Yoshida A; Noguchi S; Matsumoto K
In Vivo; 1987; 1(3):157-61. PubMed ID: 2979780
[TBL] [Abstract][Full Text] [Related]
42. Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium.
Thompson MA; Adelson MD; Kaufman LM
J Clin Endocrinol Metab; 1991 May; 72(5):1036-41. PubMed ID: 1902482
[TBL] [Abstract][Full Text] [Related]
43. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
44. Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.
Thibout D; Kraemer M; Di Benedetto M; Saffar L; Gattegno L; Derbin C; Crépin M
Anticancer Res; 1999; 19(3A):2121-6. PubMed ID: 10470159
[TBL] [Abstract][Full Text] [Related]
45. The mechanism of the G0/G1 cell cycle phase arrest induced by activation of PXR in human cells.
Zhuang W; Jia Z; Feng H; Chen J; Wang H; Guo Y; Meng C
Biomed Pharmacother; 2011 Oct; 65(7):467-73. PubMed ID: 22000295
[TBL] [Abstract][Full Text] [Related]
46. The antiovulatory activity of progesterone antagonists is not correlated to their antiprogestational potency in the rat.
Schubert C; Donath J; Michna H; Nishino Y
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):75-82. PubMed ID: 9009240
[TBL] [Abstract][Full Text] [Related]
47. Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat.
Dao B; Vanage G; Li XJ; Bardin CW; Koide SS
Contraception; 1997 Jan; 55(1):35-40. PubMed ID: 9013059
[TBL] [Abstract][Full Text] [Related]
48. In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest.
Lee WS; Chen RJ; Wang YJ; Tseng H; Jeng JH; Lin SY; Liang YC; Chen CH; Lin CH; Lin JK; Ho PY; Chu JS; Ho WL; Chen LC; Ho YS
Int J Cancer; 2003 Aug; 106(1):125-37. PubMed ID: 12794767
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor promotes cell-cycle transition from G0 to G1 phase in subcultured endothelial cells of diabetic rat thoracic aorta.
Kimura I; Honda R; Okai H; Okabe M
Jpn J Pharmacol; 2000 May; 83(1):47-55. PubMed ID: 10887940
[TBL] [Abstract][Full Text] [Related]
50. Rapid smooth muscle cell growth and endogenous prostaglandin system in spontaneously hypertensive rats.
Uehara Y; Numabe A; Kawabata Y; Nagata T; Hirawa N; Ishimitsu T; Matsuoka H; Ikeda T; Sugimoto T
Am J Hypertens; 1991 Oct; 4(10 Pt 1):806-14. PubMed ID: 1747214
[TBL] [Abstract][Full Text] [Related]
51. Modulatory action of progesterone and progesterone antagonists on hypothalamic-pituitary function.
Ortmann O; Catt KJ; Schulz KD; Emons G
Hum Reprod; 1994 Jun; 9 Suppl 1():53-62. PubMed ID: 7962470
[TBL] [Abstract][Full Text] [Related]
52. Platelet-derived growth factor blocks the cell-cycle transition from the G0 to G1 phase in subcultured angiogenic endothelial cells in rat thoracic aorta.
Kimura I; Tsuneki H; Okabe M; Ogasawara M
Jpn J Pharmacol; 1997 Aug; 74(4):303-11. PubMed ID: 9307326
[TBL] [Abstract][Full Text] [Related]
53. The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27.
Guil-Luna S; Hellmén E; Sánchez-Céspedes R; Millán Y; Martín de las Mulas J
Histol Histopathol; 2014 Jul; 29(7):949-55. PubMed ID: 24500783
[TBL] [Abstract][Full Text] [Related]
54. Down-regulation of tenascin expression by antiprogestins during terminal differentiation of rat mammary tumors.
Vollmer G; Michna H; Ebert K; Knuppen R
Cancer Res; 1992 Sep; 52(17):4642-8. PubMed ID: 1380887
[TBL] [Abstract][Full Text] [Related]
55. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs.
Hager G; Kornfehl J; Knerer B; Weigel G; Formanek M
Acta Otolaryngol; 2004 Jan; 124(1):90-6. PubMed ID: 14977084
[TBL] [Abstract][Full Text] [Related]
56. Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells.
Nigam M; Ranjan V; Srivastava S; Sharma R; Balapure AK
Life Sci; 2008 Mar; 82(11-12):577-90. PubMed ID: 18279897
[TBL] [Abstract][Full Text] [Related]
57. Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells.
Relja B; Meder F; Wilhelm K; Henrich D; Marzi I; Lehnert M
Int J Mol Med; 2010 Nov; 26(5):735-41. PubMed ID: 20878096
[TBL] [Abstract][Full Text] [Related]
58. Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
Mymryk JS; Archer TK
Mol Endocrinol; 1995 Dec; 9(12):1825-34. PubMed ID: 8614418
[TBL] [Abstract][Full Text] [Related]
59. G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells.
Siu WY; Yam CH; Poon RY
FEBS Lett; 1999 Nov; 461(3):299-305. PubMed ID: 10567715
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
